SLC2A4 and diabetes mellitus: Metformin and rosiglitazone, two antidiabetic drugs, have been reported to potently decrease blood glucose levels in the clinical treatment of diabetes via activating the AMPK pathway and enhancing GLUT4 translocation [18].